Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Publish with us

Sponsors & exhibitors

Commercial opportunities

Download Salespackopens in new tab/window

Choose from a variety of sponsorship and commercial options to raise your profile and position your company as a thought leader in the community.

Reasons why being a sponsor is a brilliant marketing strategy

  • Highly targeted marketing – reach your community

  • Brand awareness & recognition – logo and advertisement placement

  • Access to knowledge – find out about new research being undertaken

  • Engage with your audience –  at the event and online

  • Media exposure - benefit from  being promoted throughout Elsevier’s marketing process

  • Enhance credibility – highlight your company’s expertise to a captive audience

  • Generate new sales & form new partnerships – with registrants, vendors and speakers

  • Leveraged lead generation -  the chance to be recommended to attendees’ connections

An exhibition will run alongside the conference sessions. Space is available on a first-come,  first-served basis. In addition, a range of commercial sponsorship  opportunities are   available.

To discuss your requirements or to book sponsorship or exhibit space please contact:

Chloe Partridge Sales Manager STMJ Conferences | Elsevier The Boulevard | Langford Lane | Kidlington | Oxford | OX5 1GB Email : [email protected] opens in new tab/window(Please do not email credit card information under any circumstances) T: +44 1865 84 3846 | F: +44 1865 84 3973 | M: +44 0777 184 0678


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.



Oxeltis is a medicinal chemistry services company created in 2010 in Montpellier, France, by former researchers from Idenix Pharmaceuticals (formerly MSD). The company has a small-scale custom synthesis business and hit and lead optimization services in various areas, such as antivirals, antibiotics, and anticancer compounds. Oxeltis’ scientific team comprises  experienced chemists with recognized expertise in specific areas of organic synthesis: heterocycles, macrocycles, nucleosides/nucleotides, phosphoramidites, modified sugars, oligo/polysaccharides, short peptides, linkers and PROTACs. The team is focused on speed of delivery, quality, and confidentiality of the services and collaborations it develops. Oxeltis has completed more than 40 projects with complex synthetic chemistry for pharmaceutical and biotechnology companies, including five of the ten largest global pharmaceutical companies. Several drug candidates delivered to its customers are in clinical development. Oxeltis works with European, Japanese, and North American start-ups, big pharma companies, and research institutions.

More information coming soon

Visit websiteopens in new tab/window



JASON is state of the art NMR processing software from JEOL! Supporting all high field and benchtop NMR systems, JASON gives you the tools to process and analyse your NMR data with ease. Designed for chemists, JASON’s automation allows you to focus on the chemistry, while having the powerful tools available to satisfy the expert. Building on JEOL’s long history in NMR spectroscopy, JASON is the forward-looking tool to help you get the most out of your data.

Visit websiteopens in new tab/window